Meeting Posters

Association between SCID screening questions flags and screen failure outcomes in major depressive disorder trials (Abstract)

Sharp
2026 Autumn Conference

WITHDRAWN (Abstract)

WITHDRAWN
2026 Autumn Conference

The development and validation of an automated secondary review model for clinical endpoint interviews (Abstract)

Worthington
2026 Autumn Conference

Comparison of CAINS and PANSS as assessments of negative symptoms in outpatients with schizophrenia in a clinical trial setting (Abstract)

Longenecker
2026 Autumn Conference

Assessing neuroplasticity and cognition with a portable platform throughout esketamine treatment for therapy-resistant depression (Abstract)

Vestring
2026 Autumn Conference

Development of the NICS Multi-Informant Clinical Formulation Toolkit: A multi-informant approach to characterizing dysregulation drivers relevant to ND (Abstract)

Novakovic
2026 Autumn Conference

Usability and adherence to remote, longitudinal assessment of EEG, cognition, mood and sleep in borderline personality disorder (Abstract)

Dyer
2026 Autumn Conference

Optimizing scoring algorithms of the MDS-UPDRS Part 3 for clinical trials in early-stage Parkinson’s disease (Abstract)

Ayasse
2026 Autumn Conference

Power analysis methods accounting for high intra-individual variability in measured cognition (Abstract)

Ayasse
2026 Autumn Conference

Prevalence and severity of PANSS worsening across schizophrenia clinical trial populations: An analysis of 33 studies (Abstract)

Kott
2026 Autumn Conference

Investigating conversational speech latency as a marker of cognitive and temporal processing during picture description tasks across CNS conditions (Abstract)

Zhang
2026 Autumn Conference

When the device changes mid-trial: Speech-based digital endpoint robustness to on-device preprocessing variability (Abstract)

Ortiz
2026 Autumn Conference

Phase 3 trial design and methodology: Treatment with DT120 (lysergide) major depressive disorder (MDD) (Abstract)

Solomon
2026 Autumn Conference

A two-minute digital cognitive task as a pre-enrichment screening method for Alzheimer’s disease trials (Abstract)

Murphy
2026 Autumn Conference

Definition and selection of generalized anxiety disorder (GAD) and major depressive disorder (MDD) patients for inclusion in Phase 3 pivotal trials (Abstract)

Jacobsen
2026 Autumn Conference

Distilling and surpassing vendor LLM scoring of depression interviews with synthetic transcripts and expert labels (Abstract)

Kolář
2026 Autumn Conference

Improving quality assurance in digital cognitive pre-screening through single-session anomaly detection (Abstract)

Taptiklis
2026 Autumn Conference

Baseline PANSS symptoms predict relapse risk in placebo-treated patients (Abstract)

Rabinowitz
2026 Autumn Conference

Machine learning detection of arousals from at-home sleep EEG device demonstrates high reliability compared to experts (Abstract)

Puryear
2026 Autumn Conference

Phase-level analytical validation of a bring-your-own-device smartphone timed up and go assessment in multiple sclerosis (Abstract)

Abreu
2026 Autumn Conference